March 9, 2020 / 8:13 PM / 3 months ago

BRIEF-Assertio Therapeutics Posts Fourth-Quarter Loss Per Share Of $2.65

March 9 (Reuters) - Assertio Therapeutics Inc:

* ASSERTIO THERAPEUTICS ANNOUNCES FOURTH-QUARTER AND FULL-YEAR 2019 FINANCIAL RESULTS

* ASSERTIO THERAPEUTICS INC - QTRLY LOSS PER SHARE $2.65

* ASSERTIO THERAPEUTICS INC - QTRLY ADJUSTED LOSS PER SHARE $0.14

* ASSERTIO THERAPEUTICS INC - QTRLY TOTAL REVENUES $59.2 MILLION Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below